biotin and estrogen positive breast cancer

Release time ：Dec-20,2024

Folic acid and estrogen receptor-positive (ER+) breast cancer represent a distinct subtype of breast cancer that correlates with the levels of folic acid and estrogen in the body. Typically, this subtype of breast cancer responds well to hormone therapy, although individual responses may vary.

Folic acid, also referred to as vitamin B9, is a water-soluble vitamin crucial for cell health and DNA synthesis. Research indicates that low folic acid levels might be linked to an increased risk of breast cancer. Conversely, elevated folic acid levels could also be associated with a higher risk of certain breast cancer types, particularly those sensitive to estrogen.

Estrogen, a female hormone, significantly influences the growth and development of breast tissue. ER+ breast cancer signifies the presence of estrogen receptors on the tumor cell surface, suggesting that tumor growth may be affected by estrogen. Hormonal therapies, such as tamoxifen, are often effective in treating this subtype of breast cancer.

The relationship between folic acid and ER+ breast cancer is intricate and multifaceted. If you have concerns about the possibility of having this subtype of breast cancer or are seeking information on reducing your risk of breast cancer, it is advisable to consult with a healthcare professional. They can offer tailored advice and guidance based on your specific circumstances.